Post by California Institute for Regenerative Medicine (CIRM)

Rare diseases affect millions of Americans, yet most still have no approved treatment. CIRM’s new Rare Disease Acceleration Through Platform Innovation and Delivery (RAPID) funding opportunity could change that. By advancing platform-based genetic therapies, RAPID creates a faster, more scalable path for developing treatments across many rare diseases. By supporting validation of platform approaches and new technology innovation, RAPID aims to accelerate technical and regulatory progress so more patients can access life-changing therapies sooner. The RAPID request for applications is now available to view, and the mandatory consultation period is officially open. Learn more about the RAPID funding opportunity on CIRM's website at https://bit.ly/4virSBE